Vermont insurers and employers are scaling back GLP-1 coverage as costs rise, leaving some patients without access. The drugs remain in high demand as studies point to benefits beyond weight loss.
New research challenges the theory that ketamine's psychedelic effects drive its therapeutic benefits for alcohol use disorder. A study of 96 participants found no link between ketamine's psychoactive experiences and improved abstinence rates. The findings suggest other mechanisms, such as brain network alterations, may explain ketamine's effectiveness in treating addiction.
Early trial of Rezatapopt shows 20% response rate in advanced cancers with p53 mutations, while researchers identify AMD3100 as potential solution to enable immunotherapy in rare liver cancer.
Global pharmaceutical companies are accelerating licensing deals for China-developed experimental medicines, with deal values reaching unprecedented levels in 2026 as firms cut costs ahead of patent expirations.
The FDA issued a Complete Response Letter for Corcept's relacorilant as a treatment for hypertension secondary to hypercortisolism, requesting additional evidence of effectiveness despite acknowledging positive trial results.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07378514 |
Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices |
NOT_YET_RECRUITING | |
| NCT07032311 |
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk |
NOT_YET_RECRUITING | NA |
| NCT06980571 |
Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections |
COMPLETED | NA |
| NCT06482112 |
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016) |
COMPLETED | PHASE2 |
| NCT05899231 |
Online Prehabilitation for Patients Awaiting Liver Transplantation |
RECRUITING | NA |
| NCT04883177 |
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) |
COMPLETED | |
| NCT04408937 |
The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. |
COMPLETED | PHASE1 |
| NCT04185454 |
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese |
COMPLETED | NA |
| NCT04116242 |
MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease |
COMPLETED | |
| NCT04014413 |
Safety and Efficacy of Fecal Microbiota Transplantation |
RECRUITING | NA |
